A533 RAD001: Phase II Trial in Relapsed/Refractory Waldenström Macroglobulinemia, the DFCI Experience

Autor:	A Sam, Marybeth Nelson, Renee Leduc, KC Anderson, W Berg, Kelly O’Connor, Diane Warren, Thomas E. Witzig, Jacob D. Soumerai, Eric N. Jacobsen, SP Treon, Daniel J. DeAngelo, P. G. Richardson, Irene M. Ghobrial, Brianna Harris, Aldo M. Roccaro, Stacey Chuma
Rok vydání:	2009
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Internal medicine Relapsed refractory medicine Waldenstrom macroglobulinemia Hematology General Medicine business medicine.disease
Zdroj:	Clinical Lymphoma and Myeloma. 9:S82-S83
ISSN:	1557-9190
DOI:	10.1016/s1557-9190(11)70614-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a6b28c467fa26a250724641bc50466f6 https://doi.org/10.1016/s1557-9190(11)70614-x Zobrazit plný text záznamu Full Text from ScienceDirect